Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?
- PMID: 25889767
- PMCID: PMC4340668
- DOI: 10.1186/s12936-015-0602-x
Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?
Abstract
Background: Artemisinin combination therapy (ACT) is first-line treatment for malaria in most endemic countries and is increasingly available in the private sector. Most studies on ACT adherence have been conducted in the public sector, with minimal data from private retailers.
Methods: Parallel studies were conducted in Tanzania, in which patients obtaining artemether-lumefantrine (AL) at 40 randomly selected public health facilities and 37 accredited drug dispensing outlets (ADDOs) were visited at home and questioned about doses taken. The effect of sector on adherence, controlling for potential confounders was assessed using logistic regression with a random effect for outlet.
Results: Of 572 health facility patients and 450 ADDO patients, 74.5% (95% CI: 69.8, 78.8) and 69.8% (95% CI: 64.6, 74.5), respectively, completed treatment and 46.0% (95% CI: 40.9, 51.2) and 34.8% (95% CI: 30.1, 39.8) took each dose at the correct time ('timely completion'). ADDO patients were wealthier, more educated, older, sought care later in the day, and were less likely to test positive for malaria than health facility patients. Controlling for patient characteristics, the adjusted odds of completed treatment and of timely completion for ADDO patients were 0.65 (95% CI: 0.43, 1.00) and 0.69 (95% CI: 0.47, 1.01) times that of health facility patients. Higher socio-economic status was associated with both adherence measures. Higher education was associated with completed treatment (adjusted OR = 1.68, 95% CI: 1.20, 2.36); obtaining AL in the evening was associated with timely completion (adjusted OR = 0.35, 95% CI: 0.19, 0.64). Factors associated with adherence in each sector were examined separately. In both sectors, recalling correct instructions was positively associated with both adherence measures. In health facility patients, but not ADDO patients, taking the first dose of AL at the outlet was associated with timely completion (adjusted OR = 2.11, 95% CI: 1.46, 3.04).
Conclusion: When controlling for patient characteristics, there was some evidence that the adjusted odds of adherence for ADDO patients was lower than that for public health facility patients. Better understanding is needed of which patient care aspects are most important for adherence, including the role of effective provision of advice.
Similar articles
-
An assessment of the malaria-related knowledge and practices of Tanzania's drug retailers: exploring the impact of drug store accreditation.BMC Health Serv Res. 2018 Mar 9;18(1):169. doi: 10.1186/s12913-018-2966-4. BMC Health Serv Res. 2018. PMID: 29523139 Free PMC article.
-
Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.Tanzan J Health Res. 2012 Apr;14(2):89-95. doi: 10.4314/thrb.v14i2.1. Tanzan J Health Res. 2012. PMID: 26591729
-
The malaria testing and treatment landscape in mainland Tanzania, 2016.Malar J. 2017 Apr 24;16(1):202. doi: 10.1186/s12936-017-1819-7. Malar J. 2017. PMID: 28521811 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD009568. doi: 10.1002/14651858.CD009568.pub2. Cochrane Database Syst Rev. 2020. PMID: 33289099 Free PMC article.
Cited by
-
Understanding the context of delays in seeking appropriate care for children with symptoms of severe malaria in Uganda.PLoS One. 2019 Jun 5;14(6):e0217262. doi: 10.1371/journal.pone.0217262. eCollection 2019. PLoS One. 2019. PMID: 31166968 Free PMC article. Clinical Trial.
-
Artemether-lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study.Antimicrob Resist Infect Control. 2020 Nov 10;9(1):184. doi: 10.1186/s13756-020-00846-y. Antimicrob Resist Infect Control. 2020. PMID: 33168093 Free PMC article.
-
The economic impact of substandard and falsified antimalarial medications in Nigeria.PLoS One. 2019 Aug 15;14(8):e0217910. doi: 10.1371/journal.pone.0217910. eCollection 2019. PLoS One. 2019. PMID: 31415560 Free PMC article.
-
Assessing the Impact of Substandard and Falsified Antimalarials in Benin.Am J Trop Med Hyg. 2021 Nov 8;106(6):1770-7. doi: 10.4269/ajtmh.21-0450. Online ahead of print. Am J Trop Med Hyg. 2021. PMID: 34749311 Free PMC article.
-
Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-Analysis.J Trop Med. 2015;2015:189232. doi: 10.1155/2015/189232. Epub 2015 May 28. J Trop Med. 2015. PMID: 26161095 Free PMC article. Review.
References
-
- WHO . World Malaria Report. Geneva: World Health Organization; 2012.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources